Effector Therapeutics Price on April 22, 2024
| EFTRDelisted Stock | USD 0.13 0.03 30.00% |
If you're considering investing in Effector Stock, it is important to understand the factors that can impact its price. As of today, the current price of Effector Therapeutics stands at 0.13, as last reported on the 30th of November, with the highest price reaching 0.17 and the lowest price hitting 0.07 during the day. We have found twenty-four technical indicators for Effector Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm Effector Therapeutics' Mean Deviation of 7.57, standard deviation of 15.18, and Variance of 230.42 to check if the risk estimate we provide is consistent with the expected return of 0.0%.
Effector Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Effector |
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| EFTR |
Based on monthly moving average Effector Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Effector Therapeutics by adding Effector Therapeutics to a well-diversified portfolio.
Effector Therapeutics Main Headline on 22nd of April 2024
Head to Head Survey eFFECTOR Therapeutics versus COMPASS Pat... by news.google.com
Head to Head Survey eFFECTOR Therapeutics versus COMPASS Pathways Defense World
Effector Therapeutics Valuation on April 22, 2024
It is possible to determine the worth of Effector Therapeutics on a given historical date. On April 22, 2024 Effector was worth 1.67 at the beginning of the trading date compared to the closed value of 1.78. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Effector Therapeutics stock. Still, in general, we apply an absolute valuation method to find Effector Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Effector Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Effector Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 1.80 | 1.80 | 1.60 | 1.70 | 197,098 | |
04/22/2024 | 1.67 | 1.87 | 1.63 | 1.78 | 177,232 |
| 1.80 | 2.00 | 1.78 | 1.94 | 149,714 |
| Backtest Effector Therapeutics | | | Effector Therapeutics History | | | Effector Therapeutics Valuation | Previous | Next |
Effector Therapeutics Trading Date Momentum on April 22, 2024
| On April 23 2024 Effector Therapeutics was traded for 1.94 at the closing time. The top price for the day was 2.00 and the lowest listed price was 1.78 . The trading volume for the day was 149.7 K. The trading history from April 23, 2024 was a factor to the next trading day price gain. The overall trading delta against the next closing price was 8.99% . The overall trading delta against the current closing price is 26.97% . |
Effector Therapeutics Fundamentals Correlations and Trends
By evaluating Effector Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Effector Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Effector financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Effector Therapeutics Stock history
Effector Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Effector is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Effector Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Effector Therapeutics stock prices may prove useful in developing a viable investing in Effector Therapeutics
eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. It has a collaboration agreement with Pfizer Inc. to develop inhibitors of eIF4E. eFFECTOR Therapeutics, Inc. was founded in 2012 and is headquartered in Solana Beach, California. Effector Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 12 people.
Effector Therapeutics Stock Technical Analysis
Effector Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
Effector Therapeutics Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
Effector Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Effector Therapeutics November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Effector Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Effector Therapeutics shares will generate the highest return on investment. By undertsting and applying Effector Therapeutics stock market strength indicators, traders can identify Effector Therapeutics entry and exit signals to maximize returns
Effector Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Effector Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Effector Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Effector to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.22) | |||
| Jensen Alpha | (5.30) | |||
| Total Risk Alpha | (7.10) | |||
| Treynor Ratio | (0.79) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Consideration for investing in Effector Stock
If you are still planning to invest in Effector Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Effector Therapeutics' history and understand the potential risks before investing.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |